{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:05:23Z","timestamp":1779836723718,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nurs"],"DOI":"10.1186\/s12912-026-04660-6","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T02:06:09Z","timestamp":1776391569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health literacy and biosimilar acceptance in people with multiple sclerosis: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Francesco","family":"Pastore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Cicolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Forastefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Domenicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"De Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Comparcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"5","key":"4660_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/btpr.2066","volume":"31","author":"LR Tsuruta","year":"2015","unstructured":"Tsuruta LR, Lopes dos M, Santos AM, Moro. Biosimilars advancements: Moving on to the future. Biotechnol Prog. 2015;31(5):1139\u201349.","journal-title":"Biotechnol Prog"},{"key":"4660_CR2","doi-asserted-by":"publisher","first-page":"104841","DOI":"10.1016\/j.msard.2023.104841","volume":"77","author":"B Greenberg","year":"2023","unstructured":"Greenberg B, Giovannoni G. A place for biosimilars in the changing multiple sclerosis treatment landscape. Mult Scler Relat Disord. 2023;77:104841.","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"4660_CR3","doi-asserted-by":"publisher","first-page":"e0003418","DOI":"10.1371\/journal.pgph.0003418","volume":"4","author":"S Malhotra","year":"2024","unstructured":"Malhotra S, et al. Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries. PLOS Glob Public Health. 2024;4(7):e0003418.","journal-title":"PLOS Glob Public Health"},{"issue":"3","key":"4660_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1001\/jamaneurol.2022.5007","volume":"80","author":"B Hemmer","year":"2023","unstructured":"Hemmer B, et al. Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial. JAMA Neurol. 2023;80(3):298\u2013307.","journal-title":"JAMA Neurol"},{"issue":"6","key":"4660_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s40259-024-00671-4","volume":"38","author":"K Selmaj","year":"2024","unstructured":"Selmaj K, et al. Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab. BioDrugs. 2024;38(6):755\u201367.","journal-title":"BioDrugs"},{"key":"4660_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fphar.2019.00809","volume":"10","author":"I Spanou","year":"2019","unstructured":"Spanou I, Mavridis T, Mitsikostas DD. Nocebo in Biosimilars and Generics in Neurology: A Systematic Review. Front Pharmacol. 2019;10:809.","journal-title":"Front Pharmacol"},{"issue":"6","key":"4660_CR7","first-page":"429","volume":"38","author":"E Car","year":"2024","unstructured":"Car E, et al. Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review. Pharmaceut Med. 2024;38(6):429\u201355.","journal-title":"Pharmaceut Med"},{"issue":"6","key":"4660_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40259-023-00620-7","volume":"37","author":"Q Wu","year":"2023","unstructured":"Wu Q, et al. Patients\u2019 Perceptions of Biosimilars: A Systematic Review. BioDrugs. 2023;37(6):829\u201341.","journal-title":"BioDrugs"},{"key":"4660_CR9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2458-12-80","volume":"12","author":"K Sorensen","year":"2012","unstructured":"Sorensen K, et al. Health literacy and public health: a systematic review and integration of definitions and models. BMC Public Health. 2012;12:80.","journal-title":"BMC Public Health"},{"key":"4660_CR10","doi-asserted-by":"publisher","first-page":"103862","DOI":"10.1016\/j.msard.2022.103862","volume":"63","author":"B Thompson","year":"2022","unstructured":"Thompson B, et al. Effectiveness of acceptance and commitment therapy for improving quality of life and mood in individuals with multiple sclerosis: A systematic review and meta-analysis. Mult Scler Relat Disord. 2022;63:103862.","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"4660_CR11","first-page":"215","volume":"35","author":"ST Oskouei","year":"2021","unstructured":"Oskouei ST, Kusmierczyk AR. Biosimilar Uptake: The Importance of Healthcare Provider Education. Pharmaceut Med. 2021;35(4):215\u201324.","journal-title":"Pharmaceut Med"},{"issue":"25","key":"4660_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.2217\/fon-2020-0486","volume":"16","author":"CF Waller","year":"2020","unstructured":"Waller CF, Friganovic A. Biosimilars in oncology: key role of nurses in patient education. Future Oncol. 2020;16(25):1931\u20139.","journal-title":"Future Oncol"},{"issue":"12","key":"4660_CR13","first-page":"S227","volume":"28","author":"A Gibofsky","year":"2022","unstructured":"Gibofsky A, Evans C, Strand V. Provider and patient knowledge gaps on biosimilars: insights from surveys. Am J Manag Care. 2022;28(12):S227\u201333.","journal-title":"Am J Manag Care"},{"issue":"1","key":"4660_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12875-023-02208-0","volume":"24","author":"AJ Sundler","year":"2023","unstructured":"Sundler AJ, et al. The patient\u2019s first point of contact (PINPOINT) - protocol of a prospective multicenter study of communication and decision-making during patient assessments by primary care registered nurses. BMC Prim Care. 2023;24(1):249.","journal-title":"BMC Prim Care"},{"key":"4660_CR15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/PPA.S104891","volume":"10","author":"I Jacobs","year":"2016","unstructured":"Jacobs I, et al. Patient attitudes and understanding about biosimilars: an international cross-sectional survey. Patient Prefer Adherence. 2016;10:937\u201348.","journal-title":"Patient Prefer Adherence"},{"issue":"7624","key":"4660_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"issue":"10","key":"4660_CR17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","volume":"24","author":"X Montalban","year":"2025","unstructured":"Montalban X, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850\u201365.","journal-title":"Lancet Neurol"},{"key":"4660_CR18","doi-asserted-by":"publisher","first-page":"876503","DOI":"10.3389\/fphar.2022.876503","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, et al. Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey. Front Pharmacol. 2022;13:876503.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4660_CR19","doi-asserted-by":"publisher","first-page":"23867","DOI":"10.1038\/s41598-025-06749-5","volume":"15","author":"PJ Schulz","year":"2025","unstructured":"Schulz PJ, Nakamoto K. Understanding health knowledge failures: uncertainty versus misinformation. Sci Rep. 2025;15(1):23867.","journal-title":"Sci Rep"},{"issue":"1","key":"4660_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1248\/bpb.b22-00429","volume":"46","author":"A Funaki","year":"2023","unstructured":"Funaki A, et al. Factors Affecting Patients\u2019 Acceptance of Switching to Biosimilars Are Disease-Dependent: A Cross-Sectional Study. Biol Pharm Bull. 2023;46(1):128\u201332.","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"4660_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","volume":"47","author":"KB Zolnierek","year":"2009","unstructured":"Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826\u201334.","journal-title":"Med Care"},{"key":"4660_CR22","doi-asserted-by":"publisher","first-page":"1551451","DOI":"10.3389\/fphar.2025.1551451","volume":"16","author":"E Choi","year":"2025","unstructured":"Choi E, Shin G, Bae S. Unaware and unpowered: evaluating patient perceptions and preferences of biosimilars in South Korea. Front Pharmacol. 2025;16:1551451.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4660_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12912-024-02099-1","volume":"23","author":"M Shaban","year":"2024","unstructured":"Shaban M, et al. Exploring the nurse-patient relationship in caring for the health priorities of older adults: qualitative study. BMC Nurs. 2024;23(1):480.","journal-title":"BMC Nurs"},{"issue":"Q3","key":"4660_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.7224\/1537-2073.2023-070","volume":"26","author":"F Pastore","year":"2024","unstructured":"Pastore F, et al. The Clinical Nurse Practitioner\u2019s Essential Role in Early Diagnosis and Management of Multiple Sclerosis in Europe: A Consensus Report. Int J MS Care. 2024;26(Q3):208\u201313.","journal-title":"Int J MS Care"},{"key":"4660_CR25","doi-asserted-by":"crossref","unstructured":"Berardinelli D, et al. Nurse-led interventions for improving medication adherence in chronic diseases: a systematic review. Healthc (Basel). 2024;12(23).","DOI":"10.3390\/healthcare12232337"},{"issue":"12","key":"4660_CR26","doi-asserted-by":"publisher","first-page":"e15006","DOI":"10.2196\/15006","volume":"8","author":"KM Davis","year":"2019","unstructured":"Davis KM, et al. Development and Implementation of a Nurse-Led Model of Care Coordination to Provide Health-Sector Continuity of Care for People With Multimorbidity: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2019;8(12):e15006.","journal-title":"JMIR Res Protoc"},{"issue":"5","key":"4660_CR27","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/jocn.17003","volume":"33","author":"D Terry","year":"2024","unstructured":"Terry D, et al. Nurse-led clinics in primary health care: A scoping review of contemporary definitions, implementation enablers and barriers and their health impact. J Clin Nurs. 2024;33(5):1724\u201338.","journal-title":"J Clin Nurs"},{"issue":"5","key":"4660_CR28","doi-asserted-by":"publisher","first-page":"e070583","DOI":"10.1136\/bmjopen-2022-070583","volume":"13","author":"X Tao","year":"2023","unstructured":"Tao X, et al. Nurse-led virtual interventions in managing chronic diseases: a protocol for a systematic review of randomised controlled trials. BMJ Open. 2023;13(5):e070583.","journal-title":"BMJ Open"},{"issue":"15\u201316","key":"4660_CR29","doi-asserted-by":"publisher","first-page":"5328","DOI":"10.1111\/jocn.16589","volume":"32","author":"CJ Kim","year":"2023","unstructured":"Kim CJ, et al. Effectiveness of nurse-led interventions on medication adherence in adults taking medication for metabolic syndrome: A systematic review and meta-analysis. J Clin Nurs. 2023;32(15\u201316):5328\u201356.","journal-title":"J Clin Nurs"}],"container-title":["BMC Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12912-026-04660-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-026-04660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-026-04660-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:35:35Z","timestamp":1779834935000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12912-026-04660-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4660"],"URL":"https:\/\/doi.org\/10.1186\/s12912-026-04660-6","relation":{},"ISSN":["1472-6955"],"issn-type":[{"value":"1472-6955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the provisions of the Italian Medicines Agency (AIFA), as outlined in Determine Pres. n. 425\/2024, this study was classified as a non-interventional observational study involving an anonymous survey, and therefore did not require prior ethical committee approval. This classification was formally confirmed by the Ethics Committee of Bari, which stated in a communication dated March 25, 2025, that no ethical opinion was needed for the study to be conducted. All participants received comprehensive information about the study\u2019s objectives, procedures, and data management protocols. Participation was entirely voluntary and based on the provision of written informed consent. The questionnaire was fully anonymous, and to safeguard privacy, completed questionnaires were sealed in envelopes by participants and deposited into a designated collection box. Personal identifiers were stored separately from survey data, ensuring complete anonymity. All procedures concerning data collection, handling, and storage were carried out in accordance with national legal requirements and the General Data Protection Regulation (GDPR) (European Parliament & Council of the European Union, 2018). All data were stored on a secure, password-protected platform accessible exclusively to the principal investigator. A trained research nurse was responsible for the individual recruitment of participants and for verifying the fulfillment of the inclusion criteria. Participants who agreed to take part in the study were provided with comprehensive information regarding the study\u2019s objectives and procedures, and informed that participation was entirely voluntary and anonymous.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"482"}}